GTCbio and the advisory board would like to invite you to the 2017 Diabetes Summit to be held April 5-7, 2017 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:

10th Diabetes Drug Discovery & Development Conference
I. Joint Plenary Session: Where do We Stand with Stem Cell Therapy in Diabetes?
II. Going Back to the Basics - Street Light Effect
III. Novel Therapeutic Targets & Strategies for Type I Diabetes
IV. Novel Therapeutic Targets & Strategies for Type II Diabetes
V. Translation to The Clinic: What's in the Pipeline

7th Diabetes Partnering & Deal-Making Conference
I. Current Trends and Future Projections for Investments
II. Partnering and Licensing Opportunities
III. Devices and Digital Aids in Diabetes Management
IV. Investment in Disease Modifying Therapies
V. Patient Entrepreneur Panel
VI. Biotech Showcase: Emerging Pipelines

Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.

We look forward to seeing you at the conference!